Zydus Defends Obvious Challenge In Zegerid Patent Row

Law360, New York (May 20, 2013, 4:50 PM EDT) -- Zydus Pharmaceuticals USA Inc., which was sued in New Jersey federal court for developing a generic version of the heartburn drug Zegerid, said on Friday that a Federal Circuit decision in a parallel case doesn't preclude it from arguing that a Santarus Inc. patent Zydus allegedly infringes is obvious.

Zydus filed a brief responding to the Federal Circuit's recent ruling in Santarus's patent infringement lawsuit against Par Pharmaceutical Cos. Inc., which held that evidence presented by Par failed to show that U.S. Patent Number 7,399,772 was...
To view the full article, register now.